Medicare Enrolled
Dr. Donald Cousineau, DO, PC
Dermatology · Gaylord, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cousineau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cousineau?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cousineau
Dr. Donald Cousineau is a dermatology specialist in Gaylord, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Cousineau performed 8,594 Medicare services across 1,651 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cousineau received a total of $5,285 from 37 pharmaceutical and/or device companies across 329 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cousineau is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 3% volume in MI
$5,285 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,594
Medicare services
Top 3% in MI for dermatology
1,651
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~477 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
2,025 | $0 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,599 | $0 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,193 | $62 | $125 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
891 | $0 | $9 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
434 | $8 | $10 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
379 | $3 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
285 | $10 | $25 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
230 | $3 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
222 | $86 | $150 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
217 | $23 | $85 |
| Middle ear function test A diagnostic test used to evaluate how well the middle ear is functioning. |
178 | $12 | $50 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
113 | $1 | $16 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
108 | $9 | $75 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
82 | $21 | $85 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
73 | $18 | $75 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
71 | $1 | $25 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 59 | $20 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $29 | $50 |
| Skull X-ray, 1-3 views An X-ray imaging test of the skull using one to three different angles to visualize the bones of the head. |
55 | $25 | $100 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
52 | $16 | $25 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
51 | $43 | $125 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
28 | $35 | $165 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $41 | $75 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
26 | $24 | $100 |
| Bone density scan (DEXA) of forearm, finger, hand, or foot A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture. |
25 | $29 | $250 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
22 | $21 | $55 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
21 | $38 | $200 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
20 | $123 | $200 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
18 | $20 | $55 |
| New patient office visit, complex (60-74 min) | 15 | $95 | $250 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
15 | $37 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,285
Total received (2018-2024)
Avg $755/year across 7 years
Top 9% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
329
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,285 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$929
2023
$610
2022
$892
2021
$909
2020
$754
2019
$584
2018
$607
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$239
ABBVIE INC.
$209
Xeris Pharmaceuticals, Inc.
$129
Grifols USA, LLC
$83
Exact Sciences Corporation
$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$49
Amgen Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$25
Antares Pharma, Inc.
$22
Novo Nordisk Inc
$20
Dexcom, Inc.
$19
Lilly USA, LLC
$19
Top 3 companies account for 62.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$807
Novo Nordisk Inc
$586
ABBVIE INC.
$404
PFIZER INC.
$391
Amgen Inc.
$386
Grifols USA, LLC
$319
Sunovion Pharmaceuticals Inc.
$285
SANOFI-AVENTIS U.S. LLC
$200
Xeris Pharmaceuticals, Inc.
$195
ITI, Inc.
$152
Teva Pharmaceuticals USA, Inc.
$152
Lilly USA, LLC
$130
Otsuka America Pharmaceutical, Inc.
$124
GlaxoSmithKline, LLC.
$117
Merck Sharp & Dohme Corporation
$106
AbbVie Inc.
$105
Novartis Pharmaceuticals Corporation
$103
Exact Sciences Corporation
$99
Janssen Pharmaceuticals, Inc
$84
Bayer Healthcare Pharmaceuticals Inc.
$76
Allergan, Inc.
$73
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$49
Esperion Therapeutics, Inc.
$48
Supernus Pharmaceuticals, Inc.
$32
Daiichi Sankyo Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$25
Eisai Inc.
$24
Antares Pharma, Inc.
$22
Axsome Therapeutics, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
DEXCOM, INC.
$20
Mylan Specialty L.P.
$19
Dexcom, Inc.
$19
Flexion Therapeutics, Inc.
$17
Biohaven Pharmaceuticals, Inc.
$16
Astellas Pharma US Inc
$14
Avanir Pharmaceuticals, Inc.
$12
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AIRSUPRA · AJOVY · ANORO ELLIPTA · AUSTEDO · Aimovig · Auvelity · BOTOX · BREO · BREZTRI · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · GLASSIA · GVOKE HYPOPEN · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LATUDA · LEQVIO · LONHALA MAGNAIR · LYRICA · MYRBETRIQ · NEXLETOL · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREMARIN · Prolastin-C · Prolastin-C Liquid · Prolia · QELBREE · QULIPTA · REXULTI · RYBELSUS · Rybelsus · SEEBRI · SOLIQUA · SOLIQUA 100/33 · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · Tresiba · UBRELVY · UTIBRON · Utibron · VRAYLAR · Victoza · Wegovy · XARELTO · XYOSTED · YUPELRI · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in MI.
Geographic Context
Dermatologists within 10 mi
5
Per 100K population
19.7
County median income
$67,285
Nearest hospital
MUNSON HEALTHCARE OTSEGO MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cousineau is a clinical cardiology specialist, with above-average Medicare volume (top 3% in MI), with low-engagement industry engagement in the top 9% of MI peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cousineau experienced with ceftriaxone antibiotic injection?
Based on Medicare claims data, Dr. Cousineau performed 2,025 ceftriaxone antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cousineau receive payments from pharmaceutical companies?
Yes. Dr. Cousineau received a total of $5,285 from 37 companies across 329 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cousineau's costs compare to other dermatologists in Gaylord?
Dr. Cousineau's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cousineau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Gaylord
Browse dermatologists in Gaylord ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MI
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MI
Which MI dermatologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology